These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23272793)

  • 1. KCNE genetics and pharmacogenomics in cardiac arrhythmias: much ado about nothing?
    Abbott GW
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):49-60. PubMed ID: 23272793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
    Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
    Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac arrhythmia and thyroid dysfunction: a novel genetic link.
    Purtell K; Roepke TK; Abbott GW
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1767-70. PubMed ID: 20688187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into Cardiac IKs (KCNQ1/KCNE1) Channels Regulation.
    Wu X; Larsson HP
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation.
    Abbott GW
    Gene; 2016 Jan; 576(1 Pt 1):1-13. PubMed ID: 26410412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis.
    Abbott GW
    Gene; 2016 Nov; 593(2):249-60. PubMed ID: 27484720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics and cardiac ion channels.
    Roepke TK; Abbott GW
    Vascul Pharmacol; 2006 Feb; 44(2):90-106. PubMed ID: 16344000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular genetics in the hereditary form of long QT syndrome].
    Georgijević Milić L
    Med Pregl; 2000; 53(1-2):51-4. PubMed ID: 10953551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
    Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
    Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
    Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
    Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a cardiac ion channel mutation underlying drug-induced QT prolongation and life-threatening arrhythmias.
    Napolitano C; Schwartz PJ; Brown AM; Ronchetti E; Bianchi L; Pinnavaia A; Acquaro G; Priori SG
    J Cardiovasc Electrophysiol; 2000 Jun; 11(6):691-6. PubMed ID: 10868744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome.
    Frank-Hansen R; Larsen LA; Andersen P; Jespersgaard C; Christiansen M
    Clin Chim Acta; 2005 Jan; 351(1-2):95-100. PubMed ID: 15563876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
    Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.
    Romero L; Trenor B; Yang PC; Saiz J; Clancy CE
    J Mol Cell Cardiol; 2014 Jul; 72():126-37. PubMed ID: 24631769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The KCNE2 K⁺ channel regulatory subunit: Ubiquitous influence, complex pathobiology.
    Abbott GW
    Gene; 2015 Sep; 569(2):162-72. PubMed ID: 26123744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids produce a range of activators for heterogeneous IKs channel dysfunction.
    Bohannon BM; Wu X; Wu X; Perez ME; Liin SI; Larsson HP
    J Gen Physiol; 2020 Feb; 152(2):. PubMed ID: 31865382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome-associated mutations in KCNQ1 and KCNE1 subunits disrupt normal endosomal recycling of IKs channels.
    Seebohm G; Strutz-Seebohm N; Ureche ON; Henrion U; Baltaev R; Mack AF; Korniychuk G; Steinke K; Tapken D; Pfeufer A; Kääb S; Bucci C; Attali B; Merot J; Tavare JM; Hoppe UC; Sanguinetti MC; Lang F
    Circ Res; 2008 Dec; 103(12):1451-7. PubMed ID: 19008479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
    Tinel N; Diochot S; Borsotto M; Lazdunski M; Barhanin J
    EMBO J; 2000 Dec; 19(23):6326-30. PubMed ID: 11101505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
    Harmer SC; Tinker A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1074-6. PubMed ID: 17956282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.